U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market

U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market

 

RELEASE DATE
13-May-2008
REGION
North America
Research Code: N167-01-00-00-00
SKU: HC02031-NA-MR_07346
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02031-NA-MR_07346
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.

Table of Contents

Research Scope and Methodology

  • Scope & Segmentation
  • Research Methodology

Market Overview

  • Market Engineering Measurements
  • Technology Overview
  • Disease Overviews - Oncology
  • Disease Overviews - Autoimmune and Inflammatory Disorders
  • Disease Overviews - Organ Transplantation
  • Disease Overviews - Cardiovascular Disorders
  • Disease Overview - Infectious Diseases
  • Disease Overviews - Other Diseases
  • Industry Trends
  • Industry Challenges
  • Market Drivers
  • Market Restraints

Product Analysis

  • Oncology
  • Autoimmune and Inflammatory Disorders
  • Organ Transplantation
  • Cardiovascular Disorders
  • Infectious Diseases
  • Other Indications

Pipeline Analysis

  • Oncology
  • Autoimmune and Inflammatory Disorders
  • Organ Transplantation
  • Cardiovascular Disorders
  • Infectious Diseases
  • Other Indications
  • Additional Indications for Marketed Products

Competitive Analysis

Forecasts and Trends

Market Share Analysis

Oncology Databases

Autoimmune and Inflammatory Disorders Databases

Organ Transplant Databases

Cardiovascular Databases

Other Indications Databases

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, organ transplantation, cardiovascular disorders, infectious diseases, and other indications. Major market challenges, drivers, and restraints and identified and discussed.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N167-01-00-00-00
Is Prebook No